COLLABORATION AND LICENSE AGREEMENT by and among LANNETT COMPANY, INC. and SUNSHINE LAKE PHARMA CO., LTD. Dated as of February 5, 2021Collaboration and License Agreement • May 6th, 2021 • Lannett Co Inc • Pharmaceutical preparations
Contract Type FiledMay 6th, 2021 Company IndustryThis Collaboration and License Agreement (this “Agreement”) is entered into as of February 5, 2021 (the “Effective Date”), by and among Lannett Company, Inc., a Delaware corporation (“Lannett”), Sunshine Lake Pharma Co., Ltd., a corporation organized and existing under the laws of the People’s Republic of China, ( “HEC”). Lannett and HEC are each referred to herein by name or as a “Party”, or, collectively, as the “Parties”.
CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. COLLABORATION AND LICENSE AGREEMENT...Collaboration and License Agreement • February 6th, 2020 • Lannett Co Inc • Pharmaceutical preparations • Hong Kong
Contract Type FiledFebruary 6th, 2020 Company Industry Jurisdiction